Pfizer gets MIDC’s nod for transfer of business undertaking to Vidhi

05 Jul 2019 Evaluate

Pfizer has received approval from MIDC for the transfer of the business undertaking to Vidhi Research and Development LLP (Vidhi). The business undertaking includes the land, plant & machinery and employees, save and except certain portion of the land.

Earlier, the company had entered into Business Transfer Agreement for transfer of the Company’s business undertaking at Thane (BTA) as a going concern to Vidhi for a lump sum consideration of Rs 178 crore.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.


Pfizer Share Price

4704.00 -114.85 (-2.38%)
11-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.90
Dr. Reddys Lab 1325.50
Cipla 1329.90
Zydus Lifesciences 922.00
Lupin 2345.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×